Innovative Medicines Initiative public–private partnerships to enhance translational safety
S
Salah-Dine Chibout
D
Dominique Brees
M
Magda Chlebus
P
Philippe Detilleux
L
Loic Laplanche
J
Jonathan Moggs
S
Shashi K. Ramaiah
J
Jacques Richard
G
Gunnar Schütz
N
Nathalie Seigneuret
T
Thomas Steger-Hartmann
E
Elisabetta Vaudano
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 10
Published
October 01, 2025
Pages
727-728
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (12)
S
Salah-Dine Chibout
D
Dominique Brees
M
Magda Chlebus
P
Philippe Detilleux
L
Loic Laplanche
J
Jonathan Moggs
S
Shashi K. Ramaiah
J
Jacques Richard
G
Gunnar Schütz
N
Nathalie Seigneuret
T
Thomas Steger-Hartmann
E
Elisabetta Vaudano
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w